Hervé Curé
- Geriatrics and Gerontology top 2%
- Frailty in Older Adults 3
- Oncology top 2%
- Cancer Treatment and Pharmacology 18
- HER2/EGFR in Cancer Research 13
- Cancer Cells and Metastasis 3
- Cancer Research top 5%
- Breast Cancer Treatment Studies 18
- Genetics top 5%
-
- Brain Metastases and Treatment 4
-
- Breast Lesions and Carcinomas 8
-
- Monoclonal and Polyclonal Antibodies Research 5
- Co-authors
- P. CholletMarianne LeheurteurJean‐Yves PiergaAnthony GonçalvèsThomas BachelotFlorence DalencVéronique DièrasJulien Dômont
- Journals
- Breast Cancer Research and Treatment (5 papers)The Oncologist (4 papers)Clinical Breast Cancer (3 papers)
- Partner nations
- FranceUnited StatesLuxembourg
In The Last Decade
Hervé Curé
52 papers receiving 2.2k citations
Hit Papers
Peers
Comparison fields: 5 of 108
- Geriatrics and Gerontology 222
- Oncology 1.3k
- Cancer Research 510
- Genetics 342
- Pulmonary and Respiratory Medicine 827
Countries citing papers authored by Hervé Curé
This map shows the geographic impact of Hervé Curé's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hervé Curé with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hervé Curé more than expected).
Fields of papers citing papers by Hervé Curé
This network shows the impact of papers produced by Hervé Curé. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hervé Curé. The network helps show where Hervé Curé may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Hervé Curé, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 4 | |
| 2 | 2019 | 9 | |
| 3 | 2017 | 3 | |
| 4 | 2016 | 112 | |
| 5 | 2015 | 2 | |
| 6 | 2015 | 5 | |
| 7 | 2014 | 18 | |
| 8 | 2014 | 5 | |
| 9 | 2013 | 2 | |
| 10 | Lapatinib plus capecitabine in patients with previously untreated brain metastases from HER2-positive metastatic breast cancer (LANDSCAPE): a single-group phase 2 studybreakdown → | 2012 | 522 |
| 11 | 2008 | 39 | |
| 12 | 2008 | 18 | |
| 13 | 2007 | 7 | |
| 14 | 2006 | 39 | |
| 15 | 2006 | 9 | |
| 16 | 2006 | 22 | |
| 17 | 2006 | 3 | |
| 18 | 2006 | 47 | |
| 19 | 2002 | 54 | |
| 20 | 1994 | 148 |
About Hervé Curé
Hervé Curé is a scholar working on Oncology, Cancer Research, Geriatrics and Gerontology, Pathology and Forensic Medicine and Genetics, having authored 52 papers that have together received 2.3k indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (18 papers), Breast Cancer Treatment Studies (18 papers), HER2/EGFR in Cancer Research (13 papers), Breast Lesions and Carcinomas (8 papers), Monoclonal and Polyclonal Antibodies Research (5 papers), Brain Metastases and Treatment (4 papers), Frailty in Older Adults (3 papers) and Cancer Cells and Metastasis (3 papers). The work is most often cited by research in Geriatrics and Gerontology (222 citations), Oncology (1.3k citations), Cancer Research (510 citations), Genetics (342 citations) and Pulmonary and Respiratory Medicine (827 citations). Hervé Curé has collaborated with scholars based in France, United States and Luxembourg. Frequent co-authors include P. Chollet, Marianne Leheurteur, Jean‐Yves Pierga, Anthony Gonçalvès, Thomas Bachelot, Florence Dalenc, Véronique Dièras, Julien Dômont, Gilles Romieu and Maya Gutierrez. Their work appears in journals such as Breast Cancer Research and Treatment, The Oncologist, Clinical Breast Cancer, Cancer and Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.